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A B S T R A C T
This work aimed to evaluate the digestive stability of the peptides previously identiﬁed from a Corolase PP soy
protein hydrolysate (SPH) and to respond to the uncertainty about the merit of controlled hydrolysis. For this
purpose, we applied an empirical and theoretical analysis, determining peptide sequences, oxygen radical
scavenging (ORAC) and ACE inhibitory (iACE) activities, and the eﬀect of hydrolysis on solubility. Results
showed that during digestion most of SPH peptides were degraded as smaller ones. However, both SPH
bioactivities improved signiﬁcantly after digestion (3.9 ± 0.1 μmol TE/mg protein for ORAC and
IC50= 52 ± 4μg protein/mL for iACE) with similar values for soy protein isolate (SPI). With respect to solu-
bility, the controlled hydrolysis considerably increased this functional property. In conclusion, the results in-
dicated that controlled enzymatic hydrolysis of SPI with Corolase PP produced an ingredient more apt to be
incorporated in certain nutritional or nutraceutical formulations.
1. Introduction
Many of the physiological and functional properties of proteins are
attributed to biologically active peptides normally encoded in the
parental protein sequence (Rizzello et al., 2016). Recent research has
shown that peptides from diﬀerent sources, such as dairy products,
plants, animals, and seafood have a wide range of bioactivities. > 3200
diﬀerent bioactive peptides have been reported in the database BIOPEP
(Minkiewicz, Dziuba, Iwaniak, Dziuba, & Darewicz, 2008), based on
either in vitro or in vivo studies. Most of the bioactive peptides exhibit
speciﬁc bioactivity, but some peptides have been found to exhibit
multifunctional properties. The largest number of bioactive peptides
isolated to date comes from milk proteins. However, soy is an important
alternative source of these bioactive compounds (Hartmann & Meisel,
2007; Wang & Gonzalez De Mejia, 2005). In this regard, diﬀerent stu-
dies have shown that the consumption of soy protein has several po-
sitive eﬀects on health, including antioxidant and antihypertensive
activities, cholesterol and body fat reduction, prevention of
osteoporosis, and reduction of the incidence of stomach, colorectal and
breast cancer (Singh, Yadav, & Vij, 2017).
Among the mentioned bioactivities, antioxidant capacity is con-
sidered one of the most important (Coscueta et al., 2016; Rizzello et al.,
2016). Oxidative processes have detrimental eﬀects on human health
and on the quality of food. Due to the potential risks presented by
synthetic antioxidants for health (e.g., butylated hydroxyanisole -BHA,
butylated hydroxytoluene -BHT, propyl gallate -PG and tertiary bu-
tylhydroquinone -TBHQ), the use of natural antioxidants has gained
increasing interest (Shahidi & Zhong, 2015). It has been reported that
peptides exhibit antioxidant activity due to their properties to eliminate
free radicals, donate electrons and/or chelate metals (Shahidi et al.,
2015). On the other hand, antihypertensive capacity is a bioactivity
that has been valorised with a special interest in the compounds present
in food. Hypertension has established itself as a major chronic health
problem in epidemic proportions. In mammals, one of the most im-
portant instruments to maintain the homeostasis of blood pressure and
water and salt balance is the renin-angiotensin system. Angiotensin-I
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converting enzyme (ACE) is a key factor in the mentioned system to
regulate blood pressure since its inhibition allows controlling hy-
pertension. Synthetic inhibitors, such as captopril, enalapril, alacepril,
and lisinopril, are commercially available, but their use is restricted due
to possible adverse eﬀects (García-Mora et al., 2017; Lee, Qian, & Kim,
2010). Therefore, special attention has been paid to the inhibitory ef-
fects of some biological nutraceuticals, such as bioactive peptides, on
ACE (Capriotti et al., 2015; Coscueta et al., 2016; Esteve, Marina, &
García, 2015). These peptides are very valuable because they are easily
absorbed in the body, thus representing a great alternative to synthetic
drugs (Lee et al., 2010). In the last years, the antioxidant and anti-
hypertensive potential of soy protein fractions have been reported, to-
gether with the isolation and structural characterization of the most
active peptides (Capriotti et al., 2015; González-Montoya, Ramón-
Gallegos, Robles-Ramírez, & Mora-Escobedo, 2016).
Previously, we identiﬁed peptides derived from soy protein with
potential antioxidant and antihypertensive activities (Coscueta et al.,
2016). Such peptides were obtained from the enzymatic hydrolysis of
soy protein isolate (SPI), using for the ﬁrst time the commercial enzyme
Corolase PP. The bioactive capacities of the hydrolysates obtained
presented values comparable or superior to those reported in other
works with diﬀerent enzymes and substrates (Coscueta et al., 2016).
However, bioactive peptides can undergo physiological transformations
during the passage through the gastrointestinal tract that determines
their bioavailability and activity in the organism (Escudero, Mora, &
Toldrá, 2014). Therefore, the eﬀective inclusion of bioactive peptides
into the diet requires that their active sequences resist the gastro-
intestinal digestion, in order to preserve their structure and reach the
target sites in the intestine where they exert their physiological eﬀects.
At present, information related to stability of bioactive peptides after
gastrointestinal digestion is lacking (Wang, Yadav, Smart, Tajiri, &
Basit, 2015), so we considered to obtain this relevant information for
peptides obtained with Corolase PP.
In this context, the purpose of this work is to analyse and char-
acterize the peptides generated during the in vitro simulated gastro-
intestinal digestion of soy protein hydrolysate (SPH) from Corolase PP
hydrolysis. Thus, the digestive stability of the peptides previously
identiﬁed as well as the identiﬁcation of other potentially bioactive
sequences released or encrypted in the resulting peptides must be ex-
plored. For this purpose, the bioactive motif identiﬁcation tools from
the BIOPEP server will be applied for an empirical and theoretical
analysis. In addition, considering that in vitro simulated gastrointestinal
digestion of intact soy protein has been demonstrated to signiﬁcantly
increase the antioxidant and ACE inhibition activities, the hypothesis
about the utility of the previous soy protein isolate hydrolysis is for-
mulated.
2. Materials and methods
2.1. Materials
Defatted white soybean ﬂour was obtained from Molinos Río de la
Plata (San Lorenzo, Argentina). Pepsin (800–1000 U/mg protein),
pancreatin (4×USP), angiotensin-I converting enzyme (peptidyl-di-
peptidase A, EC 3.4.15.1, 5.1 U/mg), bile salts and trolox (6- hydroxy-
2,5,7,8-tetramethyl-chroman-2-carboxylic acid) were obtained from
Sigma-Aldrich (St. Louis, MO, USA) and used without further pur-
iﬁcation. The commercial enzymatic complex Corolase PP was pur-
chased from AB Enzymes GmbH (Darmstadt, Germany). Fluorescein [3′,
6′-dihydroxyspiro (isobenzofuran-1 [3H], 9′ [9H] -xanten)-3-one] was
purchased from Fisher Scientiﬁc (Hanover Park, IL). AAPH [2,2′-azobis
(2-amidi-nopropane) dihydrochloride] was purchased from Aldrich
(Milwaukee, WI). The tripeptide Abz-Gly-Phe(NO2)-Pro was obtained
from Bachem Feinchemikalien (Bubendorf, Switzerland). Tris [tris
(hydroxymethyl) aminomethane] was obtained from Fluka (Gmbh,
Germany).
2.2. Preparation of soy protein isolate
Soy protein isolate (SPI) was prepared from defatted soybean ﬂour
by aqueous extraction as explained previously (Coscueta et al., 2016),
under controlled conditions of time and temperature: 70 °C for 1 h.
Then the extract was clariﬁed by centrifugation at 2370×g for 45min.
The supernatant was precipitated by acidiﬁcation to pH 4.5 with 2M
HCl (Merck, Damdstadt, Germany) and the insoluble fraction was col-
lected by centrifugation at 2370×g for 30min. The precipitate was
freeze dried.
2.3. Enzymatic hydrolysis
Following the methodology described in our previous work
(Coscueta et al., 2016), the SPI was hydrolysed with Corolase PP at a
ratio of enzyme: substrate (10mg enzyme/g SPI- 1% m/m). The enzy-
matic hydrolysis was conducted at optimal conditions previously es-
tablished, i.e. 50°C and pH 8.0 for 4 h (Coscueta et al., 2016). The en-
zyme was inactivated by heat treatment at 80 °C for 20min, and the
supernatant was separated from precipitate by centrifugation at
2370×g for 45min. Finally, the SPI hydrolysate (SPH) was freeze
dried.
2.4. In vitro simulated gastrointestinal digestion
In vitro simulated gastrointestinal digestion was performed for SPH
and SPI. Since the focus was on perceiving protein digestion, the si-
mulation of the digestive passage that takes place in the mouth and
esophagus, where carbohydrates are mainly aﬀected, was not per-
formed. Three independent in vitro digestion experiments were per-
formed for each sample, taking 280mg (SPH, SPI) for each experience.
6 mL of acidiﬁed water (pH 2.0) was added in each case, the pH being
adjusted to 2.0 with 1 N HCl. Then the system volume was completed
up to 7mL with the same acidiﬁed water, brought to 37 °C and stirred at
130 rpm for 20min to temper the digestive process beforehand. Before
starting the in vitro digestion (time 0), 1 mL of supernatant was removed
from each experiment. The initial stage of the in vitro simulated gas-
trointestinal digestion began at the digestion step in the stomach, the
gastric juice being simulated with pepsin at 25mg/mL, prepared in
0.1 N HCl (Aura, 2005). To each experiment, 0.3 mL of this “gastric
juice” was added and left at 37 °C shaking at 130 rpm. After 60min, the
simulating gastric passage was terminated by increasing the pH to 6.5
with 100mM NaHCO3 solution. An aliquot of 1mL of each experiment
was then withdrawn, representing the end sample of such stage. For the
intestinal stage, pancreatic juices were simulated with a 2mg/mL of
pancreatin solution and 12mg/mL bile salts diluted in 100mM
NaHCO3 solution (Laurent, Besançon, & Caporiccio, 2007). An aliquot
of 1.5mL of this pancreatic solution was added to each experiment, the
temperature was brought back to 37 °C and the stirring was lowered to
45 rpm. This stage was extended for 90min and was ﬁnalized by
freezing at−30 °C. The ﬁnal digests were called DSPI for SPI and DSPH
for SPH. Finally, initial SPI and SPH solutions as well DSPI and DSPH
were nanoﬁltered with membranes of 3000 Da pore (Amicon® Ultra-4,
Millipore), for the subsequent permeate analysis. The protein content of
the permeates was estimated by Pierce BCA Protein Assay kit following
the manufacturer’s instructions. The albumin was used as standard and
the determination of peptide concentration was based on their actual
dry weight.
2.5. Analysis of total antioxidant activity
Oxygen radical absorbance capacity (ORAC) assay was based on
that proposed by Contreras et al. (2011). Brieﬂy, the reaction was
carried out at 40 °C in 75mM phosphate buﬀer (pH 7.4) and the ﬁnal
assay mixture (200 μL) contained ﬂuorescein (70 nM), AAPH (14mM),
and either antioxidant (Trolox (9.98×10−4–7.99× 10−3 μmol/mL)
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or sample (SPI, SPH and their digests at diﬀerent concentrations)). The
ﬂuorescence was recorded during 137min (104 cycles). A FLUOstar
OPTIMA plate reader (BMG Labtech, Oﬀenburg, Germany) with 485 nm
excitation and 520 nm emission ﬁlters was used. The equipment was
controlled by the FLUOstar Control software version (1.32 R2) for
ﬂuorescence measurement. Black polystyrene 96-well microplates
(Nunc, Denmark) were used. AAPH and Trolox solutions were prepared
daily and ﬂuorescein was diluted from a stock solution (1.17mM) in
75mM phosphate buﬀer (pH 7.4). All reaction mixtures were prepared
in triplicate and at least three independent runs were performed for
each sample. Final ORAC values were expressed as μmol TE (Trolox
equivalent)/mg protein.
2.6. Measurement of ACE-inhibitory activity
The ACE-inhibitory eﬀect was measured using the ﬂuorimetric assay
of Sentandreu and Toldrá (2006), as modiﬁed by Quirós, del Contreras,
Ramos, Amigo, and Recio (2009). The method is based on the ability of
ACE to hydrolyse a speciﬁc substrate (o-aminobenzoylglycyl-p-nitro-L-
phenylalanyl-L-proline or ABz-Gly-Phe(NO2)-Pro) generating ﬂuor-
escent o-aminobenzoyl-glycine. A commercial angiotensin-I converting
enzyme (EC 3.4.15.1, 5.1 U/mg) was diluted in 5mL of a glycerol so-
lution in 50% ultra-pure water. This solution was maintained at−20 °C
until use. The stock solution was then diluted 1:24 with a 150mM Tris
buﬀer solution, pH 8.3, containing 1 μM of ZnCl2, reaching a con-
centration of 42mU/mL in the ﬁnal reaction solution. 40 μL of the
working solution of ACE were added to each well of the reaction mi-
croplate, and then adjusted to 80 μL by adding both ultra-pure water for
the control and the sample to be analysed. The enzymatic reaction was
initiated by adding 160 μL of a 0.45mM solution of ABz-Gly-Phe(NO2)-
Pro, dissolved in 150mM Tris buﬀer (pH 8.3), containing 1.125M
NaCl, mixing immediately and incubating at 37 °C. The microplate was
automatically shaken before the ﬁrst reading, and the ﬂuorescence
generated was measured for 30min. The inhibitory activity on ACE
(iACE) was expressed as the concentration capable of inhibiting the
50% of the enzymatic activity (IC50). A non-linear modelling of the
obtained data was used to calculate the IC50 values, which were ex-
pressed as mean ± SD. The measurements were made with the
FLUOstar OPTIMA plate reader with excitation ﬁlters at 350 nm and
emission at 420 nm. Black 96-well polystyrene microplates (Nunc,
Denmark) were used for the assay.
2.7. Mass spectrometry analysis
Peptides from SPH, DSPI and DSPH were detected and acquired by a
MALDI-TOF/TOF mass spectrometer (4800 Plus MALDI TOF/TOF
Analyzer, SCIEX, Framingham, MA). Each spectrum was the accumu-
lated sum of at least 2000 laser shots within the ion range at m/z
700–5000. The samples were co-crystallized with HCCA matrix (4-hy-
droxycinnamic-α-cyano acid), in a stainless steel MALDI sample plate
(Opti-TOF 384- Well insert, AB SCIEX, Framingham, MA) at room
temperature. MS data was acquired in reﬂector positive mode. Some of
the ion peptide peaks were further selected for MS/MS sequencing
analysis. Combined Peptide Mass Fingerprint (PMF)+MS/MS analysis
was performed with the Mascot software (Matrix Science, UK) using the
UniProt protein sequencing database for Glycine max taxonomic selec-
tion. Methionine oxidation was selected as a variable modiﬁcation.
To determine the bioactivity, all the identiﬁed peptides were sear-
ched against a database available online, BIOPEP (Minkiewicz et al.,
2008). For SPH peptides which coincided with those reported in our
previous study (Coscueta et al., 2016), the frequency of bioactive
fragments occurrence in peptide sequence (A) was analysed:
=A a
N
where a is the number of fragments with a given activity in a peptide
sequence, and N is the number of amino acid residues of the peptide
(Dziuba, Iwaniak, & Minkiewicz, 2003).
2.8. Solubility
The protein solubility of SPI and SPH in water was determined over
a pH range of 3.0–7.0, following the methodology of Lamsal, Jung, and
Johnson (2007). SPI and SPH were suspended in deionized water at a
ratio protein/water of 1 g/100 g. The pH of the dispersion was adjusted
with either 2M NaOH or HCl, as appropriate. The dispersions were then
stirred at room temperature for 1 h and ﬁnally they were centrifuged at
20 °C and 5000×g for 30min. The protein content in the supernatant
was measured by the Pierce BCA Protein Assay kit, using bovine serum
albumin as standard. Solubility was expressed as a percentage of the
original protein present in the supernatant. The experiments were done
in triplicate.
2.9. Statistical analysis
Statistical analysis was carried out with the aid of RStudio V
1.0.143. For signiﬁcant main eﬀects, means were considered to be
diﬀerent at a signiﬁcance level of 0.05. Data was expressed as means of
three replicates.
3. Results and discussion
3.1. Bioactivity analysis during in vitro simulated gastrointestinal digestion
During the digestive process, the gastrointestinal proteolytic en-
zymes may release bioactive peptides that are encoded inactive in the
native structure of the parent protein (Capriotti et al., 2015; Escudero
et al., 2014; Hartmann & Meisel, 2007). Likewise, both these new
bioactive peptides and those present in the dietary matrix before their
ingestion can be degraded by these same enzymes and intestinal mi-
crobial peptidases, increasing or reducing their biological activities. In
order to exert their eﬀect in vivo, it is important that the bioactive
peptides resist this degradation or improve their capacities in the pro-
cess, so as to reach the bloodstream in an active form (Escudero et al.,
2014; Wang et al., 2015). To analyse empirically the eﬀects of in vitro
simulated gastrointestinal digestion on SPI and SPH, antioxidant
(ORAC) and ACE inhibitory (iACE) activities were analysed. Since in
the data obtained the response variables are recorded more than once
on the same experimental unit, the analysis is considered as “repeated
measures”, applying then the procedure of Generalized Linear Models,
GLM (Vittinghoﬀ, Glidden, Shiboski, & McCulloch, 2011). It is im-
portant to note that the analyses were performed on the nanoﬁltration
permeate (3000 Da cut-oﬀ) of the SPH as well on the digests, enriching
in bioactive peptides (Coscueta et al., 2016) while, in the case of di-
gests, the digestive enzymes were subtracted.
Adjusted GLMs were related to ORAC and iACE with three catego-
rical predictive factors: experimental units, substrate type (SPI or SPH)
and digestion stage. Since the P-value for each model was< 0.05, there
were statistically signiﬁcant relationships between the observed re-
sponses and the predictor variables. The coeﬃcients of determination
(R2) indicated that the models, thus adjusted, explained 98.97%
(ORAC) and 99.99% (iACE) of the variability. When considering the
general digestion process, irrespective of substrate, we found signiﬁcant
diﬀerences between the diﬀerent stages (beginning of the digestion at
oral phase, end of the gastric phase, and ﬁnal of the digestion at in-
testinal phase) for both responses (ORAC, iACE). As seen in Fig. 1A, the
scavenging capacity increased signiﬁcantly during the digestion of both
substrates (SPI and SPH). In relation to iACE, Fig. 1B shows how the
IC50 of the digests decreased, which indicates an increase in their ACE
inhibitory capacity, i.e. potential antihypertensive activity. Although
there was a change in both bioactivities throughout the digestion, the
change was more marked during the ﬁrst 60min (gastric phase).
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When considering the substrates separately, signiﬁcant diﬀerences
between processes for SPI and SPH were observed for both analysed
responses. As Fig. 1A shows, the change in the ORAC values was sig-
niﬁcantly greater for the SPI, which was evident by the higher slope of
gastric stage plot. Likewise, at the end of the in vitro digestion, there
were no signiﬁcant diﬀerences (P > 0.080) between the ORAC values
shown by DSPI (3.6 ± 0.2 μmol TE/mg protein) and DSPH
(3.9 ± 0.1 μmol TE/mg protein). For iACE, despite the signiﬁcance of
the potential increase of said bioactivity the IC50 of SPH only showed a
slight variation during digestion, decreasing from 81 ± 3 μg protein/
mL to 52 ± 4 μg protein/mL. In contrast, for SPI, iACE evidenced a
radical change (Fig. 1B), decreasing its IC50 from 1095 ± 8 μg protein/
mL to 70 ± 4 μg protein/mL. Although both can be considered highly
inhibitory, at the end, DSPH had a signiﬁcant higher iACE (P < 0.005)
than DSPI.
When compared with similar studies reported in bibliography, the
ORAC values presented in this study are positioned between the most
relevant values. For example, the ORAC values at the end of the di-
gestion were lower (3.9 ± 0.1 μmol TE/mg protein) than those re-
ported by Ranamukhaarachchi, Meissner, and Moresoli (2013) under
similar conditions (5.2 μmol TE/mg protein). However, the diﬀerence
between these results may be due to the diﬀerent origin and quality of
the starting substrate. In our case, the SPI was produced in the
laboratory from soybean ﬂour of industrial quality, while a commercial
standardized high-quality preparation of SPI was used in the cited
work, and therefore diﬀerent purity grades were studied. On the other
hand, the digests produced in our study showed a greater antioxidant
capacity compared to the digests of intact amaranth protein isolate
(Ipepa) and hydrolysed with Alcalase (Hpepa), produced by Orsini
Delgado, Tironi, and Añón (2011). The authors reported ORAC values
of 1.23 ± 0.03 μmol TE/mg protein (Ipepa) and 1.20 ± 0.04 μmol
TE/mg protein (Hpepa), which are not diﬀerent (P > 0.05) as in our
case. Also, DSPI and DSPH presented scavenging values higher than
those corresponding to other naturally occurring antioxidant food
components and ingredients, such as crude bran (3.1 μmol TE/mg),
ground clove (0.9 μmol TE/mg), dry oregano (1.8 μmol TE/mg) and
ground cinnamon (1.3 μmol TE/mg) (Ranamukhaarachchi et al., 2013).
Moreover, antioxidant activities (ORAC) of pure peptides derived from
the in vitro digestion of amaranth protein from 0.1 to 4.9 μmol TE/mg
peptide have been recently reported (Orsini Delgado et al., 2016), these
values being within the same order or lower than those obtained in our
work.
In the case of iACE, when contrasting with other similar studies, we
also consider that our results are promising. In 2009 (Quirós et al.,
2009), peptides obtained from 3000 Da-permeate-water soluble extract
of milks fermented with Enterococcus faecalis were subjected to in vitro
simulated gastrointestinal digestion. During this process, some of the
peptides increased their ACE inhibitory capacity while others decreased
it. Those that improved their bioactivity were partially hydrolysed by
digestive enzymes, while those that decreased their activity were hy-
drolysed into several much smaller peptides. The highest activities were
between 14 and 428 μg peptide/mL a range that includes the results of
the present work. Recently, García-Mora et al. (2017) identiﬁed pep-
tides derived from lentil hydrolysates with Savinase and synthesized
those with the highest ACE inhibitory potential. These pure peptides
were subjected to in vitro simulated gastrointestinal digestion to analyse
their stability. iACE was observed to increase with in vitro digestion,
such as our study, with reported values between 19 and 149 μg peptide/
mL, comparable with those of DSPI and DSPH. Similarly, Escudero et al.
(2014) analysed peptides synthesized from structures identiﬁed after
the in vitro digestion of ham, thus ﬁnding the best values of iACE be-
tween 7 and 166 μg peptide/mL. By considering that the bioactive ca-
pacities of pure peptides are always markedly higher than that of ori-
ginal total hydrolysates, these results reinforce the relevant bioactivity
in our digests.
According to previous studies, the antioxidant and ACE inhibitory
activities can be maintained after digestion, especially if the peptides
are small (Escudero et al., 2014; Orsini Delgado et al., 2011; Quirós
et al., 2009). Both, the oxygen radical scavenging and the ACE in-
hibitory activities of SPH improved signiﬁcantly after in vitro digestion.
This suggests that peptides present in SPH are resistant to digestion in
the gastrointestinal tract or are partially degraded in smaller peptides,
thus maintaining its biological activity. To address this issue more
deeply, a structural analysis of the peptides produced during digestion
was carried out.
3.2. Overview of the identiﬁed peptides
Peptides arising from both SPH and the in vitro simulated gastro-
intestinal digestion were sequenced by MS/MS to identify their nature
and then analysed to ﬁnd the presence of potentially bioactive se-
quences in their structures. Composition of the peptides identiﬁed,
ranged from 8 to 25 amino acid residues (i.e. between 1054 Da and
2998 Da) for SPH and 6–23 amino acid residues (i.e. between 699 Da
and 2562 Da) for the digests. These values are similar to those reported
in other studies after a similar digestion of soy seed, soy milk protein
(Capriotti et al., 2015), and diﬀerent animal proteins (Bauchart et al.,
2006; Escudero et al., 2014). Roberts, Burney, Black, and Zaloga (1999)
established that adult animal gastrointestinal tracts can absorb
Fig. 1. Variation of bioactivity during the time of in vitro simulated gastro-
intestinal digestion. The lines display the observations of ORAC (A) and iACE
(B) for each experimental unit.
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physiologically signiﬁcant amounts of polypeptides with chain length
from 3 to 51 amino acids. A highly studied soybean peptide, lunasin
(5000 Da), has been reported in human plasma after ingestion of soy
products (Dia, Torres, de Lumen, Erdman, & Gonzalez de Mejia, 2009).
Thus, the size of peptides identiﬁed in the present work is still com-
patible with absorption by the intestinal lumen, thus allowing the
peptides to exert a nutritional or bioactive function.
The analysis of the three systems under investigation (SPH, DSPI,
and DSPH) led to the identiﬁcation of extensive number of 1410 non-
redundant peptides, distributed as follow: 549 peptides in SPH, 398 in
DSPI and 463 in DSPH. As seen in Fig. 2, peptides released after in vitro
simulated gastrointestinal digestion were clustered based on their mo-
lecular mass (Mm, Da). They showed similar proﬁles for the two sys-
tems. Most of peptides (> 80%) present in DSPI and DSPH exhibited
Mm below 1500 Da, although the 1000–1500 Da group was pre-
dominant. In the case of the SPH, the proﬁle was diﬀerent with a larger
proportion of peptides above 1500 Da (Fig. 2). Also, intact SPI after
being subjected to the in vitro digestion (DSPI) presented a peptide
proﬁle like DSPH in terms of percentage, but with an increase in the
peptide fraction below 1000 Da for this last one (Fig. 2). Further com-
parison between the three investigated systems was performed con-
sidering the overlap between the identiﬁed peptides. The analysis of
peptide sequence proﬁles showed the presence of 81 peptides common
to both DSPI and DSPH, while the SPH did not present any sequence
shared with the digests.
These results indicated that through the digestive process most of
the peptides present in the SPH were degraded to smaller peptides, with
a distribution pattern similar to that of the SPI digest. Besides, the
diﬀerences observed in peptide sequences cannot be attributed to dif-
ferent parent protein sequences since they are identical. However, as
described previously (Capriotti et al., 2015), the release of unique
peptides from the digested samples, could be attributed to the nature of
the peptidases used in the gastrointestinal digestion. The lack of spe-
ciﬁcity in protein hydrolysis is due to the random hydrolysis of pepsin
and pancreatin that produce relatively large peptides for the ﬁrst en-
zyme and peptides that diﬀer in amino acid sequence for the second
one.
3.3. Potential bioactivity of the identiﬁed peptides
In our previous study (Coscueta et al., 2016), we identiﬁed ﬁve
oligopeptides with potential bioactive capacities:
IRHFNEGDVLVIPPGVPY, IRHFNEGDVLVIPPGVPYW, IYNFREGDLIAV-
PTG, VSIIDTNSLENQLDQMPRR, and YRAELSEQDIFVIPAG. In the
present study, these peptides with marked hydrophobic character were
again obtained by hydrolysis of soy protein isolate with Corolase PP.
The analysis of their sequences with the BIOPEP database (Table 1)
showed that all of them exhibited some potential bioactivities such as
the antioxidant and inhibitory capacities of ACE and dipeptidyl pepti-
dase IV. Taking into consideration that this study focuses on the anti-
oxidant and ACE inhibitory activities, Table 1 shows that the later
stands out for its frequency of occurrence of bioactive fragments in the
peptide sequence (A). This increases the probability of obtaining mainly
ACE inhibitor peptides from the precursors.
The sequences of all the peptides identiﬁed for each sample were
analysed with the bioactive motif identiﬁcation tools of the BIOPEP
database, considering sequences with more than two amino acids. The
main potential bioactivities identiﬁed correspond to antioxidant and
ACE inhibitory capacities. Table S1 (Supplementary Material) shows all
the identiﬁed peptides that possess either antioxidant or ACE inhibitory
motifs. Although the ﬁve oligopeptides mentioned above were partially
degraded during in vitro digestion, their major bioactive fragments were
retained in the resulting structures. This indicates that, despite the
structures were not very stable under the conditions of the digestive
system, probably their bioactivities are maintained and can even im-
prove.
Furthermore, we identiﬁed a peptide present in both DSPI and
DSPH that was previously reported in other works (Capriotti et al.,
2015; Chen, Muramoto, & Yamauchi, 1995). This peptide whose se-
quence is LLPHHADADY, comes from the alpha subunit of beta-con-
glycinin (position 200–209 in the complete sequence), and has a sig-
niﬁcant antioxidant activity. Chen et al. (1995) attributed this property
to the presence of histidine residues in the amino acid sequence, mainly
the LLPHH fragment. In the case of SPH, we observed that such peptide
was encrypted in other oligopeptides and released during in vitro
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Fig. 2. Percentage of peptides present in each sample (SPH, DSPI and DSPH),
clustered according to molecular mass.
Table 1
Oligopeptides previously identiﬁed in the SPH with their potential bioactivities,
and the corresponding frequencies of occurrence of bioactive fragments in the
peptide sequence (A).
Peptide Activity A
IRHFNEGDVLVIPPGVPY ACE inhibitor 0.5556
Antiamnestic 0.0556
Antioxidative 0.1111
Antithrombotic 0.0556
Dipeptidyl peptidase IV inhibitor 0.8889
Hypotensive 0.0556
Inhibitor 0.0556
Regulating 0.0556
Stimulating 0.1111
IRHFNEGDVLVIPPGVPYW ACE inhibitor 0.5789
Antiamnestic 0.0526
Antioxidative 0.1053
Antithrombotic 0.0526
Dipeptidyl peptidase IV inhibitor 0.8947
Hypotensive 0.0526
Inhibitor 0.0526
Regulating 0.0526
Stimulating 0.1053
IYNFREGDLIAVPTG ACE inhibitor 0.8
Antioxidative 0.0667
Dipeptidyl peptidase IV inhibitor 0.6667
Stimulating 0.0667
VSIIDTNSLENQLDQMPRR ACE inhibitor 0.1053
Dipeptidyl peptidase IV inhibitor 0.5263
Stimulating 0.0526
YRAELSEQDIFVIPAG ACE inhibitor 0.375
Activating ubiquitin-mediated proteolysis 0.0625
Antioxidative 0.0625
Dipeptidyl peptidase IV inhibitor 0.5625
Stimulating 0.0625
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simulated gastrointestinal digestion.
Many other recognized bioactive motifs were still encrypted in
oligopeptides obtained by in vitro digestion for both DSPI and DSPH.
However, considering that other exopeptidases and endopeptidases also
act at in vivo gastrointestinal digestion, as well as those excreted by the
microbial ﬂora present in the intestinal lumen, it is likely that these
oligopeptides were degraded, releasing many of these encrypted
bioactive sequences (Capriotti et al., 2015).
3.4. Hydrolyse or not hydrolyse?
When analysed the antioxidant and ACE inhibitory properties gen-
erated by in vitro simulated gastrointestinal digestion, both substrates
(SPI and SPH) were observed to present interesting characteristics in
addition to the widely known nutritional ones. This allows us to aﬃrm
that the pre-hydrolysis with Corolase PP does not clearly improve the
analysed bioactivities of the intact soy protein isolate. Therefore, these
bioactive properties should not be considered a categorical parameter
to contrast and decide the application of either SPI or Corolase PP SPH
in nutritional or nutraceutical formulations. When an ingredient is in-
corporated into a product, other technologically important parameters,
such as the functional properties, should be considered. These func-
tional properties are: solubility, water retention capacity, foaming,
gelling, emulsifying and fat binding properties (Zayas, 1997). These
properties are attributed to both intrinsic factors (molecular structure
and composition) and extrinsic factors (temperature, pH and presence
of chemical compounds). When these factors are modiﬁed the func-
tional properties of the proteins also change. Particularly, in our study
we analysed the solubility.
Fig. 3 shows the water solubility proﬁle of SPH and its corre-
sponding control (SPI). As expected, the solubility of both SPI and SPH
was greater on both sides of the isoelectric point (pH 4.5). The hy-
drolysis with Corolase PP increased the SPI solubility, the SPH solubi-
lity at pH 7 being approximately 4-fold higher than that of SPI. It is
known that partial denaturation of the ﬁnal product occurs in the iso-
lation process of the soy protein (Lamsal et al., 2007), due to the ag-
gressive conditions of acid precipitation during the separation of glo-
bulins from the whey compounds. However, our results showed that
this can be reversed by enzymatic hydrolysis with Corolase PP, which
agrees with other studies (Lamsal et al., 2007; Panyam & Kilara, 1996;
Tsumura et al., 2005). The increase in solubility with hydrolysis can be
attributed to the increase in the number of ionizable amino and car-
boxyl groups, exposed after the peptide bond cleavage (Lamsal et al.,
2007; Panyam & Kilara, 1996), that leads, among other things, to the
production of soluble peptides (Lamsal et al., 2007; Tsumura et al.,
2005). Lamsal et al. (2007) found that the hydrolysis of SPI with bro-
melain not only increased the protein solubility, but also modiﬁed its
rheological properties, thus producing ingredients suitable for appli-
cations in baby foods, yogurts and soups. In another study, SPI was
hydrolysed with diﬀerent commercial enzymes. It was found an in-
crease in protein solubility at pH 7.0 and 4.5, as well as an increase in
the emulsifying capacity and the ability to undergo thermal aggregation
(Kim, Park, & Rhee, 1990).
Based on our results, we consider that the controlled enzymatic
hydrolysis of SPI with Corolase PP is a very useful tool for generating
ingredients with improved functional properties, thus conserving nu-
tritional and bioactive qualities of the starting material. On the other
hand, for industries that require ingredients with more concentrated or
reﬁned bioactive peptides, the enzymatic hydrolysis followed by ade-
quate downstream operations is an eﬀective and sustainable way to
obtain them. Therefore, “hydrolyse or not hydrolyse” depends on the
purpose but we may assure that several advantages are introduced via
hydrolysis if food applications are sought.
4. Conclusions
Our in vitro results allow us to think of an in vivo scenario in which
the peptides present in the studied hydrolysate, administered orally,
could maintain their sequence integrity in the gastrointestinal tract or
break up into new smaller bioactive peptides able to reach the blood-
stream. At the end of the in vitro simulated gastrointestinal digestion,
DSPI and DSPH exhibit similar antioxidant capacity and diﬀerent ACE
inhibitory activity each other. DSPI presents ORAC values of
3.6 ± 0.2 μmol TE/mg protein and iACE (IC50) of 70 ± 4 μg protein/
mL. DSPH presents ORAC values of 3.9 ± 0.1 μmol TE/mg protein and
iACE (IC50) of 52 ± 4 μg protein/mL.
From a technological point of view, the hydrolysis of soy protein
with Corolase PP increases the solubility of the intact SPI between pH
3–7. For example, at pH 7 the solubility of SPH was approximately 4-
fold higher than that of SPI. Finally, it can be highlighted that the en-
zymatic hydrolysis of the SPI with Corolase PP is a suitable tool to
produce ingredients with a better solubility than the intact SPI, main-
taining the nutritional and bioactive properties. However, other func-
tional properties should be further studied as well as to validate
through in vivo studies the bioactive capacities established.
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